Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2019) 63 P574 | DOI: 10.1530/endoabs.63.P574

Institut National de Nutrition de Tunis, Tunis, Tunisia.


Introduction: In most cases, the management of gestational diabetes is based on self-monitoring and dietary monitoring. The use of insulin therapy may be necessary if glycemic targets are not achieved. The aim of this work is to determine the factors involved in the use of insulin therapy during gestational diabetes.

Methods: It was a descriptive study performed in 150 diabetic pregnant women hospitalized in our department for monthly metabolic control. Each patient received a complete clinical examination and biological assessment.

Results: The average age of the patients was 33 years old. The average term of discovery for gestational diabetes was 28.6±4.2 AS. A history of gestational diabetes was found in 25.1% of pregnant women. Pregnancy was programmed in 38% of cases, of which 84% had balanced diabetes during hospitalization (mean HBA1c 6.33%). Type 1 diabetes was found in 48% of patients. The average duration of diabetes progression was 9 years. Diet alone only achieved glycemic goals in 24% of our patients. The use of insulin therapy was necessary in 76%. A 3-injections pattern of rapid insulin was prescribed in 46% of gestants and a 2-injections pattern in 12%.The analytical study showed a positive association between the onset of gestational diabetes and the following factors: recurrence, the term early-onset (<24 AS), and age over 35 years.

Conclusion: Switching to early insulin therapy after failure of diet alone is increasingly necessary to prevent maternal-fetal complications.

Volume 63

21st European Congress of Endocrinology

Lyon, France
18 May 2019 - 21 May 2019

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts